These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20714897)

  • 1. Survival after pancreaticoduodenectomy for ampullary cancer is not affected by age.
    Yeh CC; Jeng YM; Ho CM; Hu RH; Chang HP; Tien YW
    World J Surg; 2010 Dec; 34(12):2945-52. PubMed ID: 20714897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
    Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.
    Park HM; Park SJ; Han SS; Hong SK; Hong EK; Kim SW
    Medicine (Baltimore); 2019 Nov; 98(44):e17711. PubMed ID: 31689805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
    de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
    J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.
    Qiao QL; Zhao YG; Ye ML; Yang YM; Zhao JX; Huang YT; Wan YL
    World J Surg; 2007 Jan; 31(1):137-43; discussion 144-6. PubMed ID: 17171495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
    Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
    J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
    Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma.
    Chavez MT; Sharpe JP; O'Brien T; Patton KT; Portnoy DC; VanderWalde NA; Deneve JL; Shibata D; Behrman SW; Dickson PV
    Am J Surg; 2017 Nov; 214(5):856-861. PubMed ID: 28285709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater.
    Murakami T; Matsuyama R; Ueda M; Mochizuki Y; Homma Y; Kameda K; Yazawa K; Izumisawa Y; Fukushima T; Kamimukai N; Yoshida K; Kamiya N; Hoffman RM; Endo I
    World J Surg Oncol; 2019 Aug; 17(1):140. PubMed ID: 31399104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of PTEN is associated with improved prognosis in patients with ampullary adenocarcinoma after pancreaticoduodenectomy.
    Shroff S; Overman MJ; Rashid A; Shroff RT; Wang H; Chatterjee D; Katz MH; Lee JE; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Arch Pathol Lab Med; 2013 Nov; 137(11):1619-26. PubMed ID: 24168499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
    El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors.
    Sommerville CA; Limongelli P; Pai M; Ahmad R; Stamp G; Habib NA; Williamson RC; Jiao LR
    J Surg Oncol; 2009 Dec; 100(8):651-6. PubMed ID: 19722229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma.
    Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Lin YW; Yang DM; Yau MP; Cho CY
    Hepatogastroenterology; 2004; 51(59):1495-9. PubMed ID: 15362785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.
    Schueneman A; Goggins M; Ensor J; Saka B; Neishaboori N; Lee S; Maitra A; Varadhachary G; Rezaee N; Wolfgang C; Adsay V; Wang H; Overman MJ
    Br J Cancer; 2015 Jun; 113(1):64-8. PubMed ID: 25989273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
    Liu F; Shen D; Ma Y; Song Q; Wang H
    J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms.
    Chapman BC; Gleisner A; Ibrahim-Zada I; Overbey DM; Paniccia A; Meguid C; Brauer B; Gajdos C; McCarter MD; Schulick RD; Edil BH
    Surg Endosc; 2018 Feb; 32(2):915-922. PubMed ID: 28779245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.